Yves Janin

Title: Yves Janin: Innovator in Medicinal Chemistry

Introduction

Yves Janin is a notable inventor based in Paris, France, recognized for his contributions to medicinal chemistry. He holds a patent that showcases his innovative approach to developing compounds with potential therapeutic applications.

Latest Patents

Yves Janin's most recent patent is titled "Substituted thieno[2,3-c]pyrazoles, process for preparing them, compositions containing them, and use thereof." This patent details compounds of formula (I), where R1 and R3 have specific meanings as described in the documentation. The compounds are presented in all isomeric forms and include their salts. The patent outlines processes for preparing these compounds and intermediates, as well as their use as medicaments, particularly as anti-cancer agents.

Career Highlights

Yves Janin is associated with Aventis Pharma S.A., a prominent company in the pharmaceutical industry. His work focuses on the development of innovative compounds that can lead to significant advancements in cancer treatment.

Collaborations

Throughout his career, Yves Janin has collaborated with esteemed colleagues, including Jean-Christophe Carry and Gilles Doerflinger. These partnerships have contributed to the advancement of research and development in the field of medicinal chemistry.

Conclusion

Yves Janin's work exemplifies the impact of innovation in the pharmaceutical industry, particularly in the fight against cancer. His contributions through patents and collaborations highlight the importance of research in developing effective treatments.